Biohub Uses AI and CRISPR to Identify Psoriasis Drug Targets
Researchers at Biohub, supported by the Chan Zuckerberg Initiative co-founded by Priscilla Chan, have combined AI and genetic screening to identify new drug targets for psoriasis. Their study, published in Nature Communications, revealed two biological pathways that may help control skin inflammation linked to this chronic disease.
TOI Science·

